Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Anticancer Research|January 25, 2008
Surgical management in lung metastases from colorectal cancerJ Dahabre, M Vasilaki, G P Stathopoulos, et al.
Anticancer Research|November 1, 1996
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parametersG P Stathopoulos, C N Baxevanis, N G Papadopoulos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrenceG P Stathopoulos, Ch Papadimitriou, G Aravantinos, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinomaM M Konstadoulakis, P T Antonakis, B G Tsibloulis, et al.
Cancer|October 20, 1999
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinomaA Giatromanolaki, G P Stathopoulos, E Tsiompanou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, D Mavroudis, N Tsavaris, et al.
Oncology Reports|November 18, 2004
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapyGeorge P Stathopoulos, Sotiris K Rigatos, Nicos A Malamos, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2000
Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomasI F Voutsas, C N Baxevanis, A D Gritzapis, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2006
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimensChristos Kosmas, Nicolas Tsavaris, Konstantinos Syrigos, et al.
Anti-Cancer Drugs|December 17, 2009
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I studyGeorge P Stathopoulos, Alexandros Ardavanis, Pavlos Papakotoulas, et al.
Pageof 15